During the Personalized Medicine Coalition's 16th Annual State of Personalized Medicine Luncheon, U.S. National Institutes of Health Director Monica Bertagnolli outlined her thoughts on the future of biomedical research and personalized medicine.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on June 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This hybrid workshop will examine how researchers could more meaningfully engage and sustain interactions with historically underrepresented communities in research to foster their participation in genomics and precision health studies. Learn more at https://www.nationalacademies.org/event/42785_07-2024_sustaining-community-engagement-in-genomics-research-a-workshop.
The 2024 Next Generation Dx Summit will explore trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. Learn more at https://www.nextgenerationdx.com/.
The Individualizing Medicine Conference is dedicated to unraveling the intricacies of population -omics, digital -omics, functional -omics, and rare disease -omics, and their vital role in patient care. Learn more at https://individualizingmedicineconference.mayo.edu/.
McDermott+Consulting organizes the +Dx Diagnostics Forum to provide members of the laboratory diagnostics community with key insights from industry innovators, thought leaders, regulators, and decision-makers. The forum covers the regulatory, legislative, and market developments shaping the future of the diagnostics space.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on September 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on September 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This webinar will provide an overview of recent research conducted by the National Pharmaceutical Council and Johnson & Johnson, followed by a panel discussion with patient group experts to address important questions related to the U.S. Food and Drug Administration's Accelerated Approval program.
The Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship convenes an audience of leading cancer researchers, entrepreneurs, investors, business executives, and advocates.
The Advancing Precision Medicine Annual Conference and Exhibition is designed to serve as a hub of knowledge exchange, collaboration, and innovation for researchers, clinicians, and industry professionals.
The Annual Personalized Medicine Conference is designed to provide attendees with an opportunity to develop collaborative solutions to shared challenges in personalized medicine. Participants will exchange views with leading business executives, clinicians, journalists, and patient advocates in an intimate conference setting. Learn more at www.personalizedmedicineconference.org.